ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 227279 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 227279; 2) Community: the network communities that were significantly associated with the response to NSC 227279; 3) Molecule: the relationships between components within communities and NSC 227279; 4) MDR: the compounds that were significantly associated with the NSC 227279.

NSC Compound Enrichment Correlation
NSC 625499 Antimony, mu-iododiiodo[mu-(4-thiomorpholinecarbodi- thioato-S(4),S(4')]bis(4-thiomorpholinecarbodithioato-S(4), S(4'))di- 0.0221886141818656 0.50902212
NSC 638287 Null 0.0221886141818656 0.57955919
NSC 661420 2-Chloro-3-(1-(4-methyl)piperazino)naphthazarin 0.0221886141818656 0.8490263
NSC 671883 Null 0.0221886141818656 0.71323158
NSC 678125 1H-indazole, 3-methoxy-1-[(2-methoxyphenyl)methyl]- 5-nitro- 0.0221886141818656 -0.23689922
NSC 679092 Null 0.0221886141818656 -0.46548055
NSC 716261 Null 0.0221886141818656 -0.54748993
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.0221886141818656 0.68821652
NSC 10660 Null 0.0235234559682127 0.32952208
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0235234559682127 0.67782161
Total:107  Current:61    [First] [Prev] [Next] [Last]